Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 147

1.

Methamphetamine dependence: a closer look at treatment response and clinical characteristics associated with route of administration in outpatient treatment.

Rawson RA, Gonzales R, Marinelli-Casey P, Ang A.

Am J Addict. 2007 Jul-Aug;16(4):291-9.

PMID:
17661197
[PubMed - indexed for MEDLINE]
2.

Drug court treatment for methamphetamine dependence: treatment response and posttreatment outcomes.

Marinelli-Casey P, Gonzales R, Hillhouse M, Ang A, Zweben J, Cohen J, Hora PF, Rawson RA; Methamphetamine Treatment Project Corporate Authors.

J Subst Abuse Treat. 2008 Mar;34(2):242-8. Epub 2007 Jun 27.

PMID:
17596903
[PubMed - indexed for MEDLINE]
3.

Characteristics and harms associated with injecting versus smoking methamphetamine among methamphetamine treatment entrants.

McKetin R, Ross J, Kelly E, Baker A, Lee N, Lubman DI, Mattick R.

Drug Alcohol Rev. 2008 May;27(3):277-85. doi: 10.1080/09595230801919486.

PMID:
18368609
[PubMed - indexed for MEDLINE]
4.

Predicting in-treatment performance and post-treatment outcomes in methamphetamine users.

Hillhouse MP, Marinelli-Casey P, Gonzales R, Ang A, Rawson RA; Methamphetamine Treatment Project Corporate Authors.

Addiction. 2007 Apr;102 Suppl 1:84-95.

PMID:
17493057
[PubMed - indexed for MEDLINE]
5.

Socio-demographic factors associated with methamphetamine treatment contact among dependent methamphetamine users in Sydney, Australia.

McKetin R, Kelly E.

Drug Alcohol Rev. 2007 Mar;26(2):161-8.

PMID:
17364851
[PubMed - indexed for MEDLINE]
6.

Two-year outcomes of treatment for methamphetamine use.

Brecht ML, Greenwell L, von Mayrhauser C, Anglin MD.

J Psychoactive Drugs. 2006 Nov;Suppl 3:415-26.

PMID:
17357533
[PubMed - indexed for MEDLINE]
7.

Clinical course and outcomes of methamphetamine-dependent adults with psychosis.

Glasner-Edwards S, Mooney LJ, Marinelli-Casey P, Hillhouse M, Ang A, Rawson R; Methamphetamine Treatment Project Corporate Authors.

J Subst Abuse Treat. 2008 Dec;35(4):445-50. doi: 10.1016/j.jsat.2007.12.004. Epub 2008 Feb 21.

PMID:
18294802
[PubMed - indexed for MEDLINE]
8.

Methamphetamine treatment: trends and predictors of retention and completion in a large state treatment system (1992-2002).

Brecht ML, Greenwell L, Anglin MD.

J Subst Abuse Treat. 2005 Dec;29(4):295-306.

PMID:
16311182
[PubMed - indexed for MEDLINE]
9.

Health-related quality of life trajectories of methamphetamine-dependent individuals as a function of treatment completion and continued care over a 1-year period.

Gonzales R, Ang A, Marinelli-Casey P, Glik DC, Iguchi MY, Rawson RA; Methamphetamine Treatment Project Corporate Authors.

J Subst Abuse Treat. 2009 Dec;37(4):353-61. doi: 10.1016/j.jsat.2009.04.001. Epub 2009 Jun 23.

PMID:
19553066
[PubMed - indexed for MEDLINE]
10.

Crystal methamphetamine smoking among regular ecstasy users in Australia: increases in use and associations with harm.

Kinner SA, Degenhardt L.

Drug Alcohol Rev. 2008 May;27(3):292-300. doi: 10.1080/09595230801919452.

PMID:
18368611
[PubMed - indexed for MEDLINE]
11.

Methamphetamine users in northern Thailand: changing demographics and risks for HIV and STD among treatment-seeking substance abusers.

Beyrer C, Razak MH, Jittiwutikarn J, Suriyanon V, Vongchak T, Srirak N, Kawichai S, Tovanabutra S, Rungruengthanakit K, Sawanpanyalert P, Sripaipan T, Celentano DD.

Int J STD AIDS. 2004 Oct;15(10):697-704.

PMID:
15479508
[PubMed - indexed for MEDLINE]
12.

Status of methamphetamine users 2-5 years after outpatient treatment.

Rawson RA, Huber A, Brethen P, Obert J, Gulati V, Shoptaw S, Ling W.

J Addict Dis. 2002;21(1):107-19.

PMID:
11831496
[PubMed - indexed for MEDLINE]
13.

Psychopathology in methamphetamine-dependent adults 3 years after treatment.

Glasner-Edwards S, Mooney LJ, Marinelli-Casey P, Hillhouse M, Ang A, Rawson RA; Methamphetamine Treatment Project Corporate Authors.

Drug Alcohol Rev. 2010 Jan;29(1):12-20. doi: 10.1111/j.1465-3362.2009.00081.x.

PMID:
20078677
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Treatment outcomes among women and men methamphetamine abusers in California.

Hser YI, Evans E, Huang YC.

J Subst Abuse Treat. 2005 Jan;28(1):77-85.

PMID:
15723735
[PubMed - indexed for MEDLINE]
15.

A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence.

Shearer J, Darke S, Rodgers C, Slade T, van Beek I, Lewis J, Brady D, McKetin R, Mattick RP, Wodak A.

Addiction. 2009 Feb;104(2):224-33. doi: 10.1111/j.1360-0443.2008.02437.x.

PMID:
19149817
[PubMed - indexed for MEDLINE]
16.
17.

Predictors of cardiovascular response to methamphetamine administration in methamphetamine-dependent individuals.

Fleury G, De La Garza R 2nd, Mahoney JJ 3rd, Evans SE, Newton TF.

Am J Addict. 2008 Mar-Apr;17(2):103-10. doi: 10.1080/10550490701861078.

PMID:
18393052
[PubMed - indexed for MEDLINE]
18.

Social-cognitive difficulties in former users of methamphetamine.

Henry JD, Mazur M, Rendell PG.

Br J Clin Psychol. 2009 Sep;48(Pt 3):323-7. doi: 10.1348/000712609X435742. Epub 2009 Apr 25.

PMID:
19397848
[PubMed - indexed for MEDLINE]
19.

Identifying methamphetamine users at risk for major depressive disorder: findings from the methamphetamine treatment project at three-year follow-up.

Glasner-Edwards S, Mooney LJ, Marinelli-Casey P, Hillhouse M, Ang A, Rawson R; Methamphetamine Treatment Project.

Am J Addict. 2008 Mar-Apr;17(2):99-102. doi: 10.1080/10550490701861110.

PMID:
18393051
[PubMed - indexed for MEDLINE]
20.

An emerging problem: methamphetamine abuse among treatment seeking youth.

Gonzales R, Ang A, McCann MJ, Rawson RA.

Subst Abus. 2008;29(2):71-80. doi: 10.1080/08897070802093312.

PMID:
19042326
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk